Patent US5106386A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5106386A Expired / Lapsed US ⏱️ 0.0 years remaining

Catheter

Assignee: LIGHTWAVE ABLATIOIN SYSTEMS
•
Filing: 1990-11-02
•
Granted: 1992-04-21
•
Expires: 2010-11-02
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A technique for percutaneous treatment of idiopathic hypertrophic subaortic stenosis (IHSS) and hypertrophic cardiomyopathy (HCM). IHSS and HCM are diseases of the heart in which the septum of the left ventricle thickens resulting in reduced ventricular performance. Current treatments involve drug therapy or a medical intervention called an interoperative myotomy/myectomy using the Morrow procedure. The present invention uses laser energy delivered via fiber optics placed percutaneously to irradiate the thickened septum to reduce tissue volume of the septum and enhance left ventricular function.

Inventors

  • 👤 Jeffrey M. Isner
  • 👤 Richard Clarke

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 15:26
CPC Classifications
A; A61; A61B; A61B18/00; A61B18/18; A61B18/20; A61B18/22; A61B18/24; A61B18/245; A61N; A61N1/00; A61N1/02; A61N1/04; A61N1/05; A61N1/056; A61N1/057; A61B17/00; A61B17/34; A61B2017/348; A61B2017/3482; A61B2017/3484; A61B2017/3488; A61B2018/00005; A61B2018/00011; A61B90/00; A61B90/39; A61M; A61M25/00; A61M2025/0098

Claims Analysis

Total Claims: 3
Claim 1
Independent Claim 175 words
A process for treating hypertophic cardiomyopathy in idiopathic hypertrophic subaortic stenosis in a patient comprising the steps of: a. percutaneously entering a blood vessel of said patient with a distal end of a catheter assembly, said catheter assembly comprising a lumen through which runs an optical fiber and a single fixation wire; b. advancing said distal end of said catheter assembly until positioned adjacent myocardial tissue in the heart of said patient; c. fixing aid distal end of said catheter assembly adjacent said myocardial tissue by urging a sigmoidal bend of said catheter assembly into contact with the inner walls of said heart and by advancing said fixation wire in said catheter assembly distally so that said fixation wire penetrates tissue of said heart; d. advancing a distal end of said optical fiber within said catheter assembly; e. coupling a proximal end of said optical fiber to an output of a medical laser; and, f. irradiating said myocardial tissue with laser energy transferred from said medical laser to said distal end of said optical fiber.
Claim 2
Dependent Claim 175 words
A process for treating hypertophic cardiomyopathy in idiopathic hypertrophic subaortic stenosis in a patient comprising the steps of: a. percutaneously entering a blood vessel of said patient with a distal end of a catheter assembly, said catheter assembly comprising a lumen through which runs an optical fiber and a single fixation wire; b. advancing said distal end of said catheter assembly until positioned adjacent myocardial tissue in the heart of said patient; c. fixing aid distal end of said catheter assembly adjacent said myocardial tissue by urging a sigmoidal bend of said catheter assembly into contact with the inner walls of said heart and by advancing said fixation wire in said catheter assembly distally so that said fixation wire penetrates tissue of said heart; d. advancing a distal end of said optical fiber within said catheter assembly; e. coupling a proximal end of said optical fiber to an output of a medical laser; and, f. irradiating said myocardial tissue with laser energy transferred from said medical laser to said distal end of said optical fiber.
Claim 3
Dependent Claim 49 words
A process according to claim 1 further comprising the steps of: a. repositioning said distal end of said catheter assembly until positioned adjacent other myocardial tissue; and, b. irradiating said other myocardial tissue with laser energy transferred from said medical laser to said distal end of said optical fiber.

References Cited (Backward Citations)

US4785815A Cited
US4854315A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1995-04-21 1995-10-21 1996-04-21 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1999-04-21 1999-10-21 2000-04-21 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2003-04-21 2003-10-21 2004-04-21 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag